Greg Fenton



dynaCERT Inc.
Latest Comments
image_pdfimage_print

Greg Fenton of Zentek discusses recent news including a NASDAQ listing and a distribution agreement

In this InvestorIntel interview with host Tracy Weslosky, Zentek Ltd. (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg Fenton […]


Greg Fenton and Byron King discuss Zentek’s highly innovative graphene Icephobic coatings for aircraft and wind turbine lifetime and safety improvement

In a recent InvestorIntel interview, Byron King spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about […]


Greg Fenton on Zentek’s approval for Nasdaq listing and the expanding use of its highly effective anti-microbial ZenGUARD™ coating

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about […]


Zentek is well positioned to commercialize several revolutionary nanotech graphene health products in 2022

Zentek Ltd. (TSXV: ZEN) (formerly ZEN Graphene Solutions Ltd.) is a trail blazing company in the world of  nanotechnology and […]


Greg Fenton on the significant medical market interest in Zentek’s ZENGuard™ nanotech coatings, plus its new carbon-based icephobic coating

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of Zentek Ltd. (TSXV: ZEN) about Zentek’s new icephobic […]


ZEN Graphene’s Greg Fenton discusses Health Canada’s approval of the ‘gold standard’ for face masks

In a recent InvestorIntel interview, Tracy Weslosky spoke with Greg Fenton, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: […]


ZEN Graphene is changing the world one nanomaterial at a time

Scientists have not unanimously settled on a precise definition of nanomaterials, but agree that they are partially characterized by their […]


Greg Fenton on how ZEN Graphene’s disease detection technology will “revolutionize the way testing is done”

In a recent InvestorIntel interview, Tracy Weslosky speaks with Greg Fenton, CEO and Director of ZEN Graphene Solutions Ltd. (TSXV: […]


Dr Dube and Greg Fenton on ZEN’s potential graphene-based antibiotic, antiviral and antifungal compound

In a recent InvestorIntel interview, Peter Clausi speaks with Dr. Francis Dube, Executive Chairman, and Greg Fenton, CEO and Director […]